Poland’s Quiet Pivot From Generics To Innovative Treatments

 
• By David Wild

Poland is slowly expanding beyond its position as a central European generics hub. More established companies are adding innovative medicine pipelines and a small number of biotechs are making international deals.  

Flag of Poland, full background
An Appetite For Risk And More EU Funding Have Fueled Biotech Growth In Poland • Source: Shutterstock

More from Global Vision

More from In Vivo